Vascular endothelial growth factor 936 C>T polymorphism increased oral cancer risk: Evidence from a meta-analysis

Genetic Testing and Molecular Biomarkers

Volumn 17, Issue 7, 2013, Pages 543-547

  Mandal, Raju Kumar ^a   Yadav, Suraj Singh ^b   Panda, Aditya K ^c   Khattri, Sanjay ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

^c Institute of Materials Science   (India)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ARTICLE; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; DNA POLYMORPHISM; DOMINANT GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; GENOTYPE; HOMOZYGOSITY; HUMAN; META ANALYSIS; MOUTH CANCER; RECESSIVE GENE;

HUMANS; MOUTH NEOPLASMS; ODDS RATIO; POLYMORPHISM, GENETIC; RISK; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84879892304     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2013.0020     Document Type: Article

References (22)

1. Cheng CY, Chang CS, Liu CJ, et al. (2008) Vascular endothelial growth factor 936 C/T polymorphism is associated with vascular invasion in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106:79-84.
2. de Nigris F, Crudele V, Giovane A, et al. (2010) CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy. Proc Natl Acad Sci U S A 107:14484-14489.
3. Der Simonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188.
4. Egger M, Davey Smith G, Schneider M, et al. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634.
5. Ferrara N (2002) VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2:795-803.
6. Ferrara N, Gerber HP, Le Couter J (2003) The biology of VEGF and its receptors. Nat Med 9:669-676.
7. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182-1186.
8. Higgins JP, Thompson SG, Deeks JJ, et al. (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-560.
9. Jemal A, Bray F, Center MM, et al. (2011) Global cancer statistics. CA Cancer J Clin 1:69-90.
10. Kämmerer PW, Toyoshima T, Eletr S, et al. (2010) Single nucle-otide polymorphisms of the vascular endothelial growth factor gene associated with incidence of oral squamous cell carcinoma. J Oral Pathol Med 39:786-792.
11. Lin YC, Yeh CJ, Wang LH, et al. (2012) The effect of CCND1 +870A>G and VEGF +936C >T polymorphisms on oral cancer development and disease-free survival in a Taiwan population. Oral Oncol 48:535-540.
12. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748.
13. McDowell JD (2006) An overview of epidemiology and common risk factors for oral squamous cell carcinoma. Otolaryngol Clin North Am 39:277-294.
14. Nakamura M, Abe Y, Tokunaga T (2002) Pathological significance of vascular endothelial growth factor A isoform expression in human cancer. Pathol Int 52:331-339.
15. Shang ZJ, Li JR, Li ZB (2002) Circulating levels of vascular en-dothelial growth factor in patients with oral squamous cell carcinoma. Int J Oral Maxillofac Surg 31:495-498.
16. Smith BD, Smith GL, Carter D, et al. (2000) Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol 18:2046-2052.
17. Supic G, Jovic N, Kozomara R, et al. (2011) Interaction between the MTHFR C677T polymorphism and alcohol impact on oral cancer risk and multiple DNA methylation of tumor-related genes. J Dent Res 90:65-70.
18. Supic G, Jovic N, Zeljic K, et al. (2012) Association of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patients. Oral Oncol 48:1171-1177.
19. Uehara M, Sano K, Ikeda H, et al. (2004) Expression of vascular endothelial growth factor and prognosis of oral squamous cell carcinoma. Oral Oncol 40:321-325.
20. Wu R, Li B (1999) A multiplicative-epistatic model for analyzing interspecific differences in outcrossing species. Biometrics 55: 355-365.
21. Xu B, Li JM, Tong N, et al. (2010) VEGFA +936C >T polymorphism and cancer risk: a meta-analysis. Cancer Genet Cytogenet 198:7-14.
22. Yapijakis C, Vairaktaris E, Vassiliou S, et al. (2007) The low VEGF production allele of the +936C/T polymorphism is strongly associated with increased risk for oral cancer. J Cancer Res Clin Oncol 133:787-791.